Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation

Combination of oncolytic virotherapy with immunomodulators is emerging as a promising therapeutic strategy for numerous tumor entities. In this study, we developed measles Schwarz vaccine strain vectors encoding immunomodulators to support different phases in the establishment of antitumor immune re...

Full description

Saved in:
Bibliographic Details
Main Authors: Veinalde, Rūta (Author) , Großardt, Christian (Author) , Hartmann, Laura (Author) , Jäger, Dirk (Author) , Kalle, Christof von (Author) , Ungerechts, Guy (Author) , Engeland, Christine Elisabeth (Author)
Format: Article (Journal)
Language:English
Published: 2017 Jan 31
In: OncoImmunology
Year: 2017, Volume: 6, Issue: 4
ISSN:2162-402X
DOI:10.1080/2162402X.2017.1285992
Online Access:Verlag, Volltext: http://dx.doi.org/10.1080/2162402X.2017.1285992
Verlag, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414860/
Get full text
Author Notes:Rūta Veinalde, Christian Grossardt, Laura Hartmann, Marie-Claude Bourgeois-Daigneault, John C. Bell, Dirk Jäger, Christof von Kalle, Guy Ungerechts, and Christine E. Engeland

MARC

LEADER 00000caa a2200000 c 4500
001 1580706851
003 DE-627
005 20220815002506.0
007 cr uuu---uuuuu
008 180905s2017 xx |||||o 00| ||eng c
024 7 |a 10.1080/2162402X.2017.1285992  |2 doi 
035 |a (DE-627)1580706851 
035 |a (DE-576)510706851 
035 |a (DE-599)BSZ510706851 
035 |a (OCoLC)1341017939 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Veinalde, Rūta  |e VerfasserIn  |0 (DE-588)1136804471  |0 (DE-627)893597589  |0 (DE-576)490853757  |4 aut 
245 1 0 |a Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation  |c Rūta Veinalde, Christian Grossardt, Laura Hartmann, Marie-Claude Bourgeois-Daigneault, John C. Bell, Dirk Jäger, Christof von Kalle, Guy Ungerechts, and Christine E. Engeland 
264 1 |c 2017 Jan 31 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.09.2018 
520 |a Combination of oncolytic virotherapy with immunomodulators is emerging as a promising therapeutic strategy for numerous tumor entities. In this study, we developed measles Schwarz vaccine strain vectors encoding immunomodulators to support different phases in the establishment of antitumor immune responses. Therapeutic efficacy of the novel vectors was evaluated in the immunocompetent MC38cea tumor model. We identified vectors encoding an IL-12 fusion protein (MeVac FmIL-12) and an antibody against PD-L1 (MeVac anti-PD-L1), respectively, as the most effective. Treatment of established tumors with MeVac FmIL-12 achieved 90% complete remissions. Profiling of the tumor immune microenvironment revealed activation of a type 1 T helper cell-directed response, with MeVac FmIL-12 ensuring potent early natural killer and effector T cell activation as well as upregulation of the effector cytokines IFN-γ and TNF-α. CD8+ T cells were found to be essential for the therapeutic efficacy of MeVac FmIL-12. Results of this study present MeVac FmIL-12 as a novel approach for targeted IL-12 delivery and elucidate mechanisms of successful immunovirotherapy. 
700 1 |a Großardt, Christian  |e VerfasserIn  |0 (DE-588)1044668512  |0 (DE-627)772407045  |0 (DE-576)398026408  |4 aut 
700 1 |a Hartmann, Laura  |d 1990-  |e VerfasserIn  |0 (DE-588)1166276864  |0 (DE-627)1030288763  |0 (DE-576)51070672X  |4 aut 
700 1 |a Jäger, Dirk  |d 1964-  |e VerfasserIn  |0 (DE-588)1032507535  |0 (DE-627)738505323  |0 (DE-576)380074125  |4 aut 
700 1 |a Kalle, Christof von  |d 1962-  |e VerfasserIn  |0 (DE-588)1036481115  |0 (DE-627)75107926X  |0 (DE-576)168957396  |4 aut 
700 1 |a Ungerechts, Guy  |d 1972-  |e VerfasserIn  |0 (DE-588)124557902  |0 (DE-627)363420053  |0 (DE-576)294230939  |4 aut 
700 1 |a Engeland, Christine Elisabeth  |d 1985-  |e VerfasserIn  |0 (DE-588)1025405951  |0 (DE-627)722221193  |0 (DE-576)370314670  |4 aut 
773 0 8 |i Enthalten in  |t OncoImmunology  |d Abingdon : Taylor & Franics, 2012  |g 6(2017,4) Artikel-Nummer e1285992, 11 Seiten  |h Online-Ressource  |w (DE-627)683365428  |w (DE-600)2645309-5  |w (DE-576)356728366  |x 2162-402X  |7 nnas  |a Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation 
773 1 8 |g volume:6  |g year:2017  |g number:4  |g extent:11  |a Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation 
856 4 0 |u http://dx.doi.org/10.1080/2162402X.2017.1285992  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414860/  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180905 
993 |a Article 
994 |a 2017 
998 |g 1025405951  |a Engeland, Christine Elisabeth  |m 1025405951:Engeland, Christine Elisabeth  |d 910000  |e 910000PE1025405951  |k 0/910000/  |p 9  |y j 
998 |g 124557902  |a Ungerechts, Guy  |m 124557902:Ungerechts, Guy  |d 910000  |e 910000PU124557902  |k 0/910000/  |p 8 
998 |g 1036481115  |a Kalle, Christof von  |m 1036481115:Kalle, Christof von  |d 910000  |d 700000  |d 718000  |e 910000PK1036481115  |e 700000PK1036481115  |e 718000PK1036481115  |k 0/910000/  |k 0/700000/  |k 1/700000/718000/  |p 7 
998 |g 1032507535  |a Jäger, Dirk  |m 1032507535:Jäger, Dirk  |d 910000  |e 910000PJ1032507535  |k 0/910000/  |p 6 
998 |g 1166276864  |a Hartmann, Laura  |m 1166276864:Hartmann, Laura  |d 140000  |e 140000PH1166276864  |k 0/140000/  |p 3 
998 |g 1044668512  |a Großardt, Christian  |m 1044668512:Großardt, Christian  |d 910000  |e 910000PG1044668512  |k 0/910000/  |p 2 
998 |g 1136804471  |a Veinalde, Rūta  |m 1136804471:Veinalde, Rūta  |d 910000  |e 910000PV1136804471  |k 0/910000/  |p 1  |x j 
999 |a KXP-PPN1580706851  |e 302478196X 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"language":["eng"],"titleAlt":[{"title":"Onco Immunology"}],"recId":"683365428","disp":"Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activationOncoImmunology","pubHistory":["1.2012 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"OncoImmunology","title_sort":"OncoImmunology"}],"origin":[{"dateIssuedDisp":"2012-","publisher":"Taylor & Franics ; Landes Bioscience","publisherPlace":"Abingdon ; Austin, Tex.","dateIssuedKey":"2012"}],"note":["Gesehen am 13.12.2022"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["683365428"],"issn":["2162-402X"],"zdb":["2645309-5"]},"part":{"year":"2017","extent":"11","issue":"4","volume":"6","text":"6(2017,4) Artikel-Nummer e1285992, 11 Seiten"}}],"note":["Gesehen am 05.09.2018"],"physDesc":[{"extent":"11 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1580706851"],"doi":["10.1080/2162402X.2017.1285992"]},"language":["eng"],"title":[{"title_sort":"Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation","title":"Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation"}],"person":[{"role":"aut","display":"Veinalde, Rūta","given":"Rūta","family":"Veinalde"},{"role":"aut","family":"Großardt","display":"Großardt, Christian","given":"Christian"},{"role":"aut","given":"Laura","display":"Hartmann, Laura","family":"Hartmann"},{"role":"aut","given":"Dirk","display":"Jäger, Dirk","family":"Jäger"},{"given":"Christof von","display":"Kalle, Christof von","family":"Kalle","role":"aut"},{"display":"Ungerechts, Guy","given":"Guy","family":"Ungerechts","role":"aut"},{"role":"aut","family":"Engeland","display":"Engeland, Christine Elisabeth","given":"Christine Elisabeth"}],"recId":"1580706851","name":{"displayForm":["Rūta Veinalde, Christian Grossardt, Laura Hartmann, Marie-Claude Bourgeois-Daigneault, John C. Bell, Dirk Jäger, Christof von Kalle, Guy Ungerechts, and Christine E. Engeland"]},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"2017 Jan 31"}]} 
SRT |a VEINALDERUONCOLYTICM2017